What a peptide is
Peptides for weight loss are medicines made of short chains of amino acids that copy hunger and fullness hormones. A few are FDA-approved and well studied. Many others sold online are not approved for people at all.
A peptide is a small protein. Your body makes many, including GLP-1, the gut hormone that signals fullness, and insulin, which has been used as a medicine for about 100 years. Some medicines are lab-made peptides designed to act like these hormones and last much longer.
Most peptide medicines are injected because stomach acid and enzymes break them down. The Wegovy pill is an exception: it includes an ingredient that helps semaglutide get absorbed in the stomach, which is why it must be taken on an empty stomach.
The approved weight-loss peptides
| Peptide | Brands for weight | Average loss in main trial |
|---|---|---|
| Tirzepatide | Zepbound | up to 20.9% (72 weeks) |
| Semaglutide | Wegovy, Wegovy pill | 14.9% (68 weeks, injection) |
| Liraglutide | Saxenda | 8.0% (56 weeks) |
What makes approved peptides different
- Tested in people. Each approved weight-loss peptide went through large randomized trials with thousands of people.
- Made under FDA rules. Factories are inspected, and each batch is checked for strength, purity and sterility.
- A label you can read. The prescribing information lists doses, side effects, warnings and who shouldn't take it.
- Someone is watching. Side effects reported after approval are tracked, and labels get updated.
None of that applies to a vial bought from a research-chemical website.
Research peptides and why they're risky
Some websites sell peptides labeled "for research use only, not for human consumption". These can include copies of approved drugs and investigational ones like retatrutide, which isn't FDA-approved. Nobody checks these products for the right ingredient, dose, sterility or contaminants.
The FDA has warned about unapproved GLP-1 products, and has said several popular peptides raise safety concerns when compounded. See compounded GLP-1s.
Compounding rules have also tightened. The FDA declared the tirzepatide shortage over in late 2024 and the semaglutide shortage over in early 2025, which narrowed when pharmacies may make copies of these medicines. Research-chemical sellers were never allowed to sell them for people in the first place.
Popular peptides and where they stand
| Peptide | Status as of our last review |
|---|---|
| Tirzepatide, semaglutide, liraglutide | FDA-approved for weight management under brand names |
| Tesamorelin | FDA-approved only to reduce excess belly fat in some adults with HIV, not for general weight loss |
| Retatrutide | Investigational, in phase 3 trials |
| BPC-157, AOD-9604 and similar | Not FDA-approved; the FDA has flagged possible safety risks when compounded |
Check FDA.gov for the latest, since approvals and warnings change.
Investigational, not available
Retatrutide (a triple-hormone peptide) and others are still in trials. In a phase 2 trial published in 2023, adults on the highest dose lost 24.2% of their weight on average at 48 weeks, vs 2.1% on placebo. Early results look striking, but until approval, the only legitimate way to get them is through a clinical trial. Track the pipeline on our retatrutide page.
Red flags when shopping online
- "For research use only" or "not for human consumption" on the label, sold to the public anyway.
- Freeze-dried powder you mix yourself, with doses in "units" or "clicks".
- Names of drugs that aren't approved yet, sold as if they were.
- No prescription and no licensed pharmacy.
- Before-and-after photos or influencer codes instead of trial data.
Products like these can contain the wrong amount, the wrong ingredient or bacteria. The FDA has also warned that some semaglutide sold online uses salt forms, such as semaglutide sodium, that aren't the ingredient in approved medicines.
What the research says
The evidence is strong for the three approved peptides: large randomized trials with thousands of people. For most other peptides promoted for weight loss, there are few or no good human trials, so safety and benefit are simply unknown. Unknown isn't the same as safe. If you're curious about your options, the weight-loss projection shows what approved medicines averaged in trials.
When to talk to your doctor
- If you're considering any peptide for weight loss.
- If you've used a research peptide and feel unwell, have stomach pain or an injection-site infection.
- If you want to join a clinical trial: ask how to find one near you.
Run your numbers
Keep reading



Common questions
What peptides are approved for weight loss?
Tirzepatide (Zepbound), semaglutide (Wegovy and the Wegovy pill) and liraglutide (Saxenda).
Are research peptides legal for weight loss?
Products sold "for research use only" aren't approved for human use, and their quality isn't checked by the FDA.
Is retatrutide available?
Not as an approved medicine, as of our last review. It's still in phase 3 trials.
Sources
- FDA: concerns with unapproved GLP-1 drugs used for weight loss
- FDA: human drug compounding
- Jastreboff et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). NEJM 2022
- Wilding et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). NEJM 2021
- Pi-Sunyer et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management (SCALE). NEJM 2015
Clinician review pending. Drafted from primary sources and waiting for sign-off by a licensed clinician (MD, DO or PharmD) before launch. Every number is checked against its source. Drug facts are re-checked quarterly, prices monthly and whenever a label changes. How we review · Report an error
